Indication
Dermatomyositis
Dermatomyositis is a rare, immune-mediated inflammatory myopathy characterized by systemic involvement primarily affecting the striated skeletal muscles and the skin. Read more about Dermatomyositis
5 drugs 5 manufacturers
Drugs that treat it
Common Dermatomyositis therapies.
OCTAGAM (immune globulin,gamm(IgG)/maltose/IgA greater than 50 mcg/mL)
OCTAGAM (immune globulin,gamm(IgG)/maltose/IgA greater than 50 mcg/mL)
OCTAGAM (immune globulin,gamm(IgG)/maltose/IgA greater than 50 mcg/mL)
LISRAYA (brepocitinib tosylate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDermatomyositis is a rare, immune-mediated inflammatory myopathy characterized by systemic involvement primarily affecting the striated skeletal muscles and the skin.
It presents across both pediatric and adult populations, clinically marked by progressive, symmetric proximal muscle weakness alongside distinct cutaneous eruptions such as a violaceous heliotrope rash and Gottron papules.
Pathophysiologically driven by immune complex deposition, microvascular endothelial injury, and type I interferon pathway activation, the disease can also involve extra-muscular systems, frequently causing interstitial lung disease, esophageal dysmotility, and cardiac complications, and it carries an elevated association with underlying malignancies in adults.
- nih.gov
Dermatomyositis is a rare, immune-mediated inflammatory myopathy characterized by systemic involvement primarily affecting the striated skeletal muscles and the skin
- nih.gov
Dermatomyositis is a rare, immune-mediated inflammatory myopathy characterized by systemic involvement primarily affecting the striated skeletal muscles and the skin It presents across both pediatric and adult populations, clinically marked by progressive, symmetric proximal muscle weakness alongside distinct cutaneous eruptions such as a violaceous heliotrope rash and Gottron papules
- nih.gov
It presents across both pediatric and adult populations, clinically marked by progressive, symmetric proximal muscle weakness alongside distinct cutaneous eruptions such as a violaceous heliotrope rash and Gottron papules Pathophysiologically driven by immune complex deposition, microvascular endothelial injury, and type I interferon pathway activation, the disease can also involve extra-muscular systems, frequently causing interstitial lung disease, esophageal dysmotility, and cardiac complicat...
- mhsystem.org
It presents across both pediatric and adult populations, clinically marked by progressive, symmetric proximal muscle weakness alongside distinct cutaneous eruptions such as a violaceous heliotrope rash and Gottron papules
- nih.gov
Pathophysiologically driven by immune complex deposition, microvascular endothelial injury, and type I interferon pathway activation, the disease can also involve extra-muscular systems, frequently causing interstitial lung disease, esophageal dysmotility, and cardiac complications, and it carries an elevated association with underlying malignancies in adults
Personalize your experience
Follow Dermatomyositis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.